# GRAIL, Inc.: filings

GRAL · Nasdaq · CIK 1699031 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/gral.md) · [Financials](/companies/gral/financials.md) · [Filings](/companies/gral/filings.md) · [Insiders](/companies/gral/insiders.md)

## Reports and events: 41 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 98, 144 39, 8-K 25, 3 11, SCHEDULE 13G/A 11, 10-Q 7, S-8 5, UPLOAD 5, D 4, D/A 4, SCHEDULE 13G 4, 4/A 3, CORRESP 3, DEF 14A 3, DRS/A 3, SC 13G 3, SEC STAFF LETTER 3, 10-12B/A 2, 10-K 2, 8-K/A 2, DEFA14A 2, DRS 2, DRSLTR 2, SC 13G/A 2, 10-12B 1, 144/A 1, 424B5 1, 424B7 1, CERT 1, RW 1, S-1 1, S-1/A 1, S-3ASR 1, SEC STAFF ACTION 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-06 | 20:11 ET | [10-Q](/filings/0001628280-26-054307.md) | Quarterly report, period 2026-06-30 | 0001628280-26-054307 |
| 2026-08-05 | 20:08 ET | [8-K](/filings/0001628280-26-053341.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-053341 |
| 2026-06-22 | 20:50 ET | [8-K](/filings/0001628280-26-044693.md) | 5.07 Shareholder vote results | 0001628280-26-044693 |
| 2026-06-01 | 20:07 ET | [8-K](/filings/0001628280-26-039461.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-039461 |
| 2026-05-07 | 20:09 ET | [10-Q](/filings/0001628280-26-032090.md) | Quarterly report, period 2026-03-31 | 0001628280-26-032090 |
| 2026-05-05 | 20:05 ET | [8-K](/filings/0001628280-26-030495.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-030495 |
| 2026-04-28 | 20:18 ET | [DEF 14A](/filings/0001628280-26-027946.md) | Proxy statement, period 2026-06-18 | 0001628280-26-027946 |
| 2026-03-12 | 20:40 ET | [10-K](/filings/0001628280-26-017319.md) | Annual report, period 2025-12-31 | 0001628280-26-017319 |
| 2026-02-19 | 21:18 ET | [8-K](/filings/0001699031-26-000009.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001699031-26-000009 |
| 2026-01-12 | 15:30 ET | [8-K](/filings/0001628280-26-001786.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-001786 |
| 2025-11-14 | 11:19 ET | [8-K](/filings/0001628280-25-052184.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-052184 |
| 2025-11-13 | 21:04 ET | [10-Q](/filings/0001699031-25-000193.md) | Quarterly report, period 2025-09-30 | 0001699031-25-000193 |
| 2025-11-12 | 21:03 ET | [8-K](/filings/0001699031-25-000189.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001699031-25-000189 |
| 2025-10-20 | 20:21 ET | [8-K](/filings/0001628280-25-045532.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001628280-25-045532 |
| 2025-10-16 | 21:02 ET | [8-K](/filings/0001628280-25-045239.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-045239 |
| 2025-09-18 | 01:35 ET | [8-K](/filings/0001699031-25-000180.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001699031-25-000180 |
| 2025-08-13 | 20:07 ET | [10-Q](/filings/0001699031-25-000166.md) | Quarterly report, period 2025-06-30 | 0001699031-25-000166 |
| 2025-08-12 | 20:01 ET | [8-K](/filings/0001699031-25-000162.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001699031-25-000162 |
| 2025-05-30 | 21:05 ET | [8-K](/filings/0001699031-25-000122.md) | 5.07 Shareholder vote results | 0001699031-25-000122 |
| 2025-05-16 | 20:05 ET | [8-K](/filings/0001699031-25-000120.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001699031-25-000120 |
| 2025-05-14 | 20:11 ET | [10-Q](/filings/0001699031-25-000114.md) | Quarterly report, period 2025-03-31 | 0001699031-25-000114 |
| 2025-05-13 | 20:14 ET | [8-K](/filings/0001699031-25-000110.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001699031-25-000110 |
| 2025-04-15 | 15:09 ET | [DEF 14A](/filings/0001699031-25-000075.md) | Proxy statement, period 2025-05-29 | 0001699031-25-000075 |
| 2025-04-15 | 20:06 ET | [DEF 14A](/filings/0001699031-25-000073.md) | Proxy statement, period 2025-05-29 | 0001699031-25-000073 |
| 2025-03-05 | 21:29 ET | [10-K](/filings/0001699031-25-000041.md) | Annual report, period 2024-12-31 | 0001699031-25-000041 |
| 2025-02-20 | 21:05 ET | [8-K](/filings/0001699031-25-000016.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001699031-25-000016 |
| 2025-01-15 | 17:00 ET | [8-K](/filings/0001628280-25-001580.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-001580 |
| 2024-11-13 | 21:12 ET | [10-Q](/filings/0001628280-24-047606.md) | Quarterly report, period 2024-09-30 | 0001628280-24-047606 |
| 2024-11-12 | 21:01 ET | [8-K](/filings/0001628280-24-047100.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-047100 |
| 2024-10-22 | 21:10 ET | [8-K](/filings/0001628280-24-043305.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure | 0001628280-24-043305 |
| 2024-08-13 | 20:59 ET | [10-Q](/filings/0001628280-24-036965.md) | Quarterly report, period 2024-06-30 | 0001628280-24-036965 |
| 2024-08-13 | 20:15 ET | [8-K](/filings/0001628280-24-036944.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-036944 |
| 2024-08-06 | 20:53 ET | [8-K](/filings/0001628280-24-035247.md) | 7.01 Regulation FD disclosure | 0001628280-24-035247 |
| 2024-07-02 | 20:49 ET | [8-K/A](/filings/0001628280-24-030858.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-24-030858 |
| 2024-06-27 | 21:05 ET | [8-K](/filings/0001628280-24-030355.md) | 2.06 Material impairments | 0001628280-24-030355 |
| 2024-06-24 | 21:09 ET | [8-K](/filings/0001193125-24-167037.md) | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-24-167037 |
| 2024-06-12 | 21:42 ET | [8-K](/filings/0001193125-24-159261.md) | 5.02 Departure or appointment of officers or directors | 0001193125-24-159261 |
| 2024-06-06 | 21:52 ET | [8-K/A](/filings/0001193125-24-155278.md) | 8.01 Other events | 0001193125-24-155278 |
| 2024-06-03 | 21:25 ET | [8-K](/filings/0001193125-24-153238.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-153238 |
| 2020-09-17 | 21:16 ET | [S-1/A](/filings/0001628280-20-013710.md) | Registration statement, amended | 0001628280-20-013710 |
| 2020-09-09 | 10:06 ET | [S-1](/filings/0001628279-20-000227.md) | Registration statement | 0001628279-20-000227 |

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.